[ad_1]
The controversy over the new formula of Levothyrox does not slow down the laboratory which plans to market it in 21 European countries.
France is the first market to have launched the new formula of Levothyrox in March 2017. Switzerland followed in April 2018. Despite controversy around the drug, the Merck laboratory announced that it planned to launch this new formula in 21 countries of the European Union. from 2019.
On the same subject
The German Federal Institute of Medicines and Medical Devices has recommended approval of the new formulation of Euthyrox® (Levothyroxine) from Merck in 21 country of the Union. "The procedure leads to a positive opinion for the introduction of the new Levothyrox formula in the 21 Member States concerned" rejoices the German laboratory in a statement .
" For thyroid medications a small dosage variation may impact the patient's thyroid balance, so prescribing physicians are encouraged to closely monitor patients when prescribing the new formulation and adjusting the dose individual if it is medically necessary "insists the laboratory
To read also:
Levothyrox: one million patients would have dropped the drug
6 symptoms that may indicate hypothyroidism
[ad_2]
Source link
